Literature DB >> 16179366

Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.

Alex Straiker1, Ken Mackie.   

Abstract

Depolarization-induced suppression of excitation and inhibition (DSE and DSI) appear to be important forms of short-term retrograde neuronal plasticity involving endocannabinoids (eCB) and the activation of presynaptic cannabinoid CB1 receptors. We report here that CB1-dependent DSE can be elicited from autaptic cultures of excitatory mouse hippocampal neurones. DSE in autaptic cultures is both more robust and elicited with a more physiologically relevant stimulus than has been thus far reported for conventional hippocampal cultures. An additional requirement for autaptic DSE is filled internal calcium stores. Pharmacological experiments favour a role for 2-arachidonyl glycerol (2-AG) rather than arachidonyl ethanolamide (AEA) or noladin ether as the relevant endocannabinoid to elicit DSE. In particular, the latter two compounds fail to reversibly inhibit EPSCs, a quality inconsistent with the role of bona fide eCB mediating DSE. Delta9-Tetrahydrocannabinol (delta9-THC) fails to inhibit EPSCs, yet readily occludes both DSE and EPSC inhibition by a synthetic CB1 agonist, WIN 55212-2. With long-term exposure (approximately 18 h), delta9-THC also desensitizes CB1 receptors. Lastly, a functional endocannabinoid transporter is necessary for the expression of DSE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179366      PMCID: PMC1464237          DOI: 10.1113/jphysiol.2005.091918

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  59 in total

1.  CB1 cannabinoid receptors and on-demand defense against excitotoxicity.

Authors:  Giovanni Marsicano; Sharon Goodenough; Krisztina Monory; Heike Hermann; Matthias Eder; Astrid Cannich; Shahnaz C Azad; Maria Grazia Cascio; Silvia Ortega Gutiérrez; Mario van der Stelt; Maria Luz López-Rodriguez; Emilio Casanova; Günther Schütz; Walter Zieglgänsberger; Vincenzo Di Marzo; Christian Behl; Beat Lutz
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

2.  Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.

Authors:  Jennifer Ronesi; Gregory L Gerdeman; David M Lovinger
Journal:  J Neurosci       Date:  2004-02-18       Impact factor: 6.167

3.  2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Authors:  L Hanus; S Abu-Lafi; E Fride; A Breuer; Z Vogel; D E Shalev; I Kustanovich; R Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

4.  P2X7 receptors control 2-arachidonoylglycerol production by microglial cells.

Authors:  Anke Witting; Lisa Walter; Jennifer Wacker; Thomas Möller; Nephi Stella
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

Review 5.  Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).

Authors:  Marco A Diana; Alain Marty
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

6.  A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity.

Authors:  Susana Mato; Vivien Chevaleyre; David Robbe; Angel Pazos; Pablo E Castillo; Olivier J Manzoni
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

7.  Delta 9-tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture.

Authors:  Brooke G Kelley; Stanley A Thayer
Journal:  Neuropharmacology       Date:  2004-04       Impact factor: 5.250

8.  Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

Authors:  Miriam Melis; Marco Pistis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Gian Luigi Gessa
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

9.  Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex.

Authors:  Joseph Trettel; Dale A Fortin; Eric S Levine
Journal:  J Physiol       Date:  2004-01-23       Impact factor: 5.182

10.  Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.

Authors:  Aron H Lichtman; Christopher C Shelton; Tushar Advani; Benjamin F Cravatt
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

View more
  98 in total

1.  Metabotropic suppression of excitation in murine autaptic hippocampal neurons.

Authors:  Alex Straiker; Ken Mackie
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

2.  Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol.

Authors:  Bela Szabo; Michal J Urbanski; Tiziana Bisogno; Vincenzo Di Marzo; Aitziber Mendiguren; Wolfram U Baer; Ilka Freiman
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

Review 3.  Cannabinoid receptors and endocannabinoids: evidence for new players.

Authors:  Ken Mackie; Nephi Stella
Journal:  AAPS J       Date:  2006-04-28       Impact factor: 4.009

Review 4.  Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years.

Authors:  Alex Straiker; Ken Mackie
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

5.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

6.  Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.

Authors:  Takako Ohno-Shosaku; Yuki Hashimotodani; Masato Ano; Sachi Takeda; Hiroshi Tsubokawa; Masanobu Kano
Journal:  J Physiol       Date:  2007-07-05       Impact factor: 5.182

7.  Cannabinoids as anticancer therapeutic agents.

Authors:  Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2020-04-05       Impact factor: 4.534

8.  Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.

Authors:  Michal Bajo; Marisa Roberto; Paul Schweitzer
Journal:  J Neurosci Res       Date:  2009-02-15       Impact factor: 4.164

9.  Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.

Authors:  Nicholas A Jones; Andrew J Hill; Imogen Smith; Sarah A Bevan; Claire M Williams; Benjamin J Whalley; Gary J Stephens
Journal:  J Pharmacol Exp Ther       Date:  2009-11-11       Impact factor: 4.030

Review 10.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.